{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:47:27Z","timestamp":1791136047250,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.placenta.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T09:45:38Z","timestamp":1377683138000},"page":"1059-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["First trimester hyperglycosylated human chorionic gonadotrophin in\u00a0serum \u2013 A marker of early-onset preeclampsia"],"prefix":"10.1016","volume":"34","author":[{"given":"E.","family":"Keikkala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vuorela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Laivuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Romppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.-H.","family":"Stenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2013.08.006_bib1","series-title":"The world health report 2005-make every mother and child count","year":"2005"},{"key":"10.1016\/j.placenta.2013.08.006_bib2","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Zhou","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.placenta.2013.08.006_bib3","article-title":"The role of the spiral arteries in the pathogenesis of pre-eclampsia","volume":"101","author":"Brosens","year":"1970","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.placenta.2013.08.006_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"issue":"Suppl.\u00a0A","key":"10.1016\/j.placenta.2013.08.006_bib5","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.placenta.2008.11.021","article-title":"Placental stress and pre-eclampsia: a revised view","volume":"30","author":"Redman","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2013.08.006_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1471-0528.1994.tb13182.x","article-title":"A\u00a0study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies","volume":"101","author":"Meekins","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.placenta.2013.08.006_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clinbiochem.2011.03.018","article-title":"Unified prenatal screening for Down's syndrome and pre-eclampsia","volume":"44","author":"Wald","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.placenta.2013.08.006_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pd.1970140311","article-title":"Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8\u201314 weeks","volume":"14","author":"Macintosh","year":"1994","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.placenta.2013.08.006_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/uog.8808","article-title":"Early fetal growth, PAPP-A and free beta-hCG in relation to risk of delivering a small-for-gestational age infant","volume":"37","author":"Kirkegaard","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/OGX.0b013e3182227027","article-title":"Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review","volume":"66","author":"Kuc","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.placenta.2013.08.006_bib13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/plac.2002.0944","article-title":"Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in\u00a0vitro","volume":"24","author":"Guibourdenche","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2013.08.006_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1471-0528.1996.tb09662.x","article-title":"Perinatal morbidity in chronic hypertension","volume":"103","author":"McCowan","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.placenta.2013.08.006_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bmj.38555.462685.8F","article-title":"Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort","volume":"331","author":"Skjaerven","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.placenta.2013.08.006_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bpobgyn.2011.01.007","article-title":"Pre-eclampsia: risk factors and causal models","volume":"25","author":"Trogstad","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02778058","article-title":"Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma","volume":"7","author":"Elliott","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.placenta.2013.08.006_bib19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/glycob\/cwl034","article-title":"Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography\u2013electrospray mass spectrometry","volume":"16","author":"Valmu","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.placenta.2013.08.006_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/joe.0.1720497","article-title":"Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope","volume":"172","author":"Kovalevskaya","year":"2002","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.placenta.2013.08.006_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1373\/clinchem.2010.159939","article-title":"Elimination of complement interference in immunoassay of hyperglycosylated human chorionic gonadotropin","volume":"57","author":"Stenman","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2013.08.006_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(02)00135-1","article-title":"Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG","volume":"194","author":"Kovalevskaya","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.placenta.2013.08.006_bib23","doi-asserted-by":"crossref","first-page":"E240","DOI":"10.1210\/jc.2010-0138","article-title":"Hyperglycosylated hCG is a marker of early human trophoblast invasion","volume":"95","author":"Guibourdenche","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.placenta.2013.08.006_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/pd.329","article-title":"The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia","volume":"22","author":"Bahado-Singh","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib25","first-page":"159","article-title":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia","volume":"99","author":"American College of Obstetricians and Gynecologists","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.placenta.2013.08.006_bib27","first-page":"237","article-title":"The diagnosis of altered fetal growth","volume":"15","author":"Ott","year":"1988","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.placenta.2013.08.006_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajog.2005.07.035","article-title":"Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia\/intrauterine growth restriction","volume":"194","author":"Kadyrov","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1469-0705.1997.09020094.x","article-title":"Transvaginal uterine and umbilical artery Doppler examination of 12-16 weeks and the subsequent development of pre-eclampsia and intrauterine growth retardation","volume":"9","author":"Harrington","year":"1997","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib30","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/oxfordjournals.humrep.a138465","article-title":"Comparison of colour Doppler features and pathological findings in complicated early pregnancy","volume":"9","author":"Jauniaux","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.placenta.2013.08.006_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jri.2009.10.012","article-title":"Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss","volume":"85","author":"Jeschke","year":"2010","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.placenta.2013.08.006_bib32","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1210\/en.2008-1309","article-title":"Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor","volume":"150","author":"Kane","year":"2009","journal-title":"Endocrinology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.placenta.2013.08.006_bib33","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.placenta.2011.01.009","article-title":"Review: hCG, preeclampsia and regulatory T cells","volume":"32","author":"Norris","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2013.08.006_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2005.12.047","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"Suppl.","key":"10.1016\/j.placenta.2013.08.006_bib35","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.placenta.2011.09.019","article-title":"IFPA Award in Placentology lecture: molecular regulation of human trophoblast invasion","volume":"33","author":"Knofler","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2013.08.006_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/bjp.2008.102","article-title":"Gonadotropins in doping: pharmacological basis and detection of illicit use","volume":"154","author":"Stenman","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.placenta.2013.08.006_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cca.2011.09.038","article-title":"Loss of human chorionic gonadotropin in urine during storage at\u00a0\u221220 degrees","volume":"413","author":"Lempiainen","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.placenta.2013.08.006_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1373\/clinchem.2009.134080","article-title":"Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review","volume":"56","author":"Giguere","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2013.08.006_bib39","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pd.2375","article-title":"Maternal serum placental protein 13 at 11\u201313 weeks of gestation in preeclampsia","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib41","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/uog.7621","article-title":"Maternal plasma soluble endoglin at 11\u201313 weeks' gestation in pre-eclampsia","volume":"35","author":"Foidart","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/pd.2807","article-title":"First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia","volume":"31","author":"Vandenberghe","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.placenta.2013.08.006_bib44","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.placenta.2013.08.006_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jc.2005-1076","article-title":"Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation","volume":"91","author":"Wathen","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.placenta.2013.08.006_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11\u00a0+\u00a00 to 13\u00a0+\u00a06 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/pd.2287","article-title":"First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk","volume":"29","author":"Khalil","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pd.1970130207","article-title":"Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking","volume":"13","author":"Bartels","year":"1993","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.fertnstert.2012.06.011","article-title":"Maternal body mass index and serum concentrations of human chorionic gonadotropin in very early pregnancy","volume":"98","author":"Eskild","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.placenta.2013.08.006_bib50","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0029-7844(95)00308-E","article-title":"Decreased maternal serum hCG levels with increasing gravidity and parity","volume":"86","author":"Mooney","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<699::AID-PD919>3.0.CO;2-P","article-title":"Serum markers for Down's syndrome in relation to number of previous births and maternal age","volume":"16","author":"Wald","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2013.08.006_bib52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0002-9378(93)90013-9","article-title":"Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension","volume":"169","author":"Sorensen","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib53","doi-asserted-by":"crossref","first-page":"228.e1","DOI":"10.1016\/j.ajog.2012.06.006","article-title":"Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia","volume":"207","author":"Olsen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2013.08.006_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2393-8-33","article-title":"Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis","volume":"8","author":"Morris","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.placenta.2013.08.006_bib55","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400413006917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400413006917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:49:17Z","timestamp":1758908957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400413006917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0143400413006917"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2013.08.006","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First trimester hyperglycosylated human chorionic gonadotrophin in\u00a0serum \u2013 A marker of early-onset preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}